Pfizer (PFE) shares have been inching upward recently, sparking some fresh attention from investors looking to understand ...

This sustained sell-off has wiped out approximately $18 billion in market capitalization, leaving its current value at around ...

According to a Securities and Exchange Commission (SEC) filing dated October 16, 2025, ASSET PLANNING SERVICES INC /LA/ /ADV ...

Pfizer's stock has been struggling for multiple years, and even a low valuation hasn't made it an enticing option for many ...

This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them. Pfizer (NYSE:PFE) stock is a biopharmaceutical firm that ...

By stepping out as the first biopharma to win a three-year exemption from President Donald Trump’s earlier-announced plans for 100% tariffs, in return for agreeing to manufacture more of its drugs in ...

Pfizer enters the obesity drug market with a reasonably valued deal, while valuation remains attractive and technicals show ...

Pfizer's 7%+ yield signals low market expectations amid pipeline setbacks and looming patent cliffs, but the dividend remains well-covered for now. Cost discipline is driving margin improvement, with ...